Open AccessManagement of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
Author(s) -
John Fitzgerald,
Barbara Ercole,
Dipen J. Parekh
Publication year - 2010
Publication title -
indian journal of urology/indian journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.333
H-Index - 30
eISSN - 1998-3824
pISSN - 0970-1591
DOI - 10.4103/0970-1591.60448
Subject(s) - medicine , germ cell , germ cell tumors , chemotherapy , oncology , cancer research , biochemistry , chemistry , gene
The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.